50MEDIUM

EBO

EBOS FPO NZ [EBO]
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Healthcare · ASX Small Cap
$18.8900 +0.6%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical74
Catalyst66
Sentiment50
Fundamental100
Momentum39
Risk Gate50
Get alerts when EBO's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track EBO — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Volume surging at 4.5x normal while price climbs — real buying conviction behind this move
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Cash positive / operating cashflow positive
  • Low P/S ratio (0.3x)
  • Moderate revenue growth (+13%)
  • Piotroski F-Score strong (8/9, low-confidence approx)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (5% of range)
  • New substantial holder(s) (1)
  • CANSLIM C: Positive EPS growth (13% QoQ)
  • CANSLIM I: Institutional ownership (26%)
  • Sentiment is mixed — no strong consensus either way
  • Poor risk-adjusted returns — Sharpe of -2.3 means lots of volatility for not much reward
  • RBA hiking (-3pts)
  • Technical-fundamental alignment: quality + trend

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 41% over the past year
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EBO
"What's driving EBO's score?" "How does EBO compare to peers?" "Key risks for EBO?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE NZX Capital Change Notice
NONE Notification regarding unquoted securities - EBO
NONE Update - Dividend/Distribution - EBO
HIGH Becoming a substantial holder

Recent ASX Announcements

2026-03-24 NZX Capital Change Notice
2026-03-24 Notification regarding unquoted securities - EBO
2026-03-23 Becoming a substantial holder
2026-03-20 Update - Dividend/Distribution - EBO
2026-03-20 NZX Performance Rights Update

Key Metrics

$3.9B
Market Cap
254K
Avg Volume
4.5x
Vol Ratio
$17.78 — $38.23
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
9.0%
ROE
1.8%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSweakEPS Growth: 13%
AAnnual EarningsneutralCAGR: 1%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 94%
LLeader vs LaggardlaggardRS: -4
IInstitutional SponsorshippassInst: 26%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #35 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:EBO vs ATXEBO vs PNVEBO vs IMM
Scout Pro — Deeper Analysis for EBO
Try Pro free for 30 days
Share this analysis

Track EBO and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required